These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The efficacy of a serum screening service for neural-tube defects: the South Wales experience. Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057 [TBL] [Abstract][Full Text] [Related]
8. Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse. Wilson RD J Obstet Gynaecol Can; 2016 Dec; 38(12S):S496-S511. PubMed ID: 28063560 [No Abstract] [Full Text] [Related]
9. [Prenatal alpha fetoprotein screening for defects in the neural tube]. Grob PJ Schweiz Med Wochenschr; 1978 Aug; 108(34):1302-7. PubMed ID: 80821 [TBL] [Abstract][Full Text] [Related]
10. Prevention of neural tube defects in an urban health district. Watson D; Pow M; Ellam A; Costeloe K J Epidemiol Community Health; 1983 Sep; 37(3):221-5. PubMed ID: 6194239 [TBL] [Abstract][Full Text] [Related]
11. Maternal serum alpha-fetoprotein monitoring. Council on Scientific affairs. JAMA; 1982 Mar; 247(10):1478-81. PubMed ID: 6173496 [TBL] [Abstract][Full Text] [Related]
12. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience]. Guibaud S; Capella-Bonnet M; Simplot A J Genet Hum; 1985 Sep; 33(3-4):339-45. PubMed ID: 2414399 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of screening for alpha-fetoprotein in pregnancy. Haddow JE; Milunsky A N Engl J Med; 1984 Jun; 310(25):1669-70. PubMed ID: 6203037 [No Abstract] [Full Text] [Related]
15. A clinical approach to the use of predictive values in the prenatal diagnosis of neural tube defects. Sheffield LJ; Sackett DL; Goldsmith CH; Doran TA; Allen LC Am J Obstet Gynecol; 1983 Feb; 145(3):319-24. PubMed ID: 6186144 [TBL] [Abstract][Full Text] [Related]
16. AFP-screening for all? Davies DP; Cole GF; Derbyshire F; Jones AJ Lancet; 1980 May; 1(8179):1195. PubMed ID: 6155577 [No Abstract] [Full Text] [Related]
17. Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Smith AD; Wald NJ; Cuckle HS; Stirrat GM; Bobrow M; Lagercrantz H Lancet; 1979 Mar; 1(8118):685-8. PubMed ID: 85932 [TBL] [Abstract][Full Text] [Related]
18. The ethical dimensions of policy for prenatal diagnostic technologies: the case of maternal serum alpha-fetoprotein screening. Fry ST ANS Adv Nurs Sci; 1987 Apr; 9(3):44-55. PubMed ID: 2436572 [TBL] [Abstract][Full Text] [Related]
19. alpha-fetoprotein in antenatal diagnosis of neural tube defects. Carachi R Br Med J; 1977 Nov; 2(6098):1357. PubMed ID: 73398 [No Abstract] [Full Text] [Related]
20. Maternal serum screening for neural tube defects and fetal chromosome abnormalities. Rose NC; Mennuti MT West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]